The Journal of Phytopharmacology, 2019;8(1):01-04 DOI:10.31254/phyto.2019.8101
Biological activities of Chromolena odorata (L.) King and Robinson (Asteraceae) collected from Sabah, Malaysia as protein phosphatase type-1 inhibitor
Matawali A1 , Lee PC2 , How SE2 , Jualang AG2
1. Preparatory Centre for Science and Technology, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia
2. Faculty of Science and Natural Resources, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia
*Author to whom correspondence should be addressed.
Received: 15th January, 2019 / Accepted: 26th February, 2019
Chromolena Odorata has been traditionally used as wound healer in local community. The present study investigated the anti-kinase and anti-phosphatases activities on methanolic C. odorata extract. Mutant yeast strains used are MKK1P386, MKK1P386_MSG5, PAY704-1 and PAY700-4. Bioassay guided fractionation of C. odorata revealed positive activities of hexane, ethyl acetate and chloroform partitions. Column chromatography of all partitionates later confirmed fraction F2 from chloroform extract had most favorable activity with inhibitory zone ranged between 7±0.0 mm until 15±0.0 mm. Kinetic analysis including maximum enzyme velocity (Vm) and Michealis-Menten constant (Km) were evaluated and compared for both normal and inhibited reactions. Enzyme activity with DiFMUP as substrate showed fraction F2 act as PP1 enzyme inhibitor with the Km value 0.60 mM and Vm value 200 mM/min as compared to the normal enzymatic reaction. Results provided unveil the potential of C. odorata as an effective therapeutic agent.
Chromolena Odorata, Pokok kapal terbang, Sabah, Protein phosphatase type-1.
HOW TO CITE THIS ARTICLE
Matawali A, Lee PC, How SE, Jualang AG. Biological activities of Chromolena odorata (L.) King and Robinson (Asteraceae) collected from Sabah, Malaysia as protein phosphatase type-1 inhibitor. J Phytopharmacol 2019; 8(1):01-04.
Creative Commons (CC) License-
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).
Copyright
Copyright © 2019 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.